Lukas Hainz

Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised

The prospect of biomanufacturing in space is accelerating the evolution of healthcare delivery and research in significant ways. From the unique research opportunities aboard the International Space Station (ISS) to the cutting-edge advancements in regenerative medicine, the potential of these

In the incredibly intricate world of medical diagnostics, artificial intelligence has made groundbreaking strides, especially concerning liver diseases such as biliary atresia (BA). This rare and severe condition affects infants, and delays in diagnosis can lead to significant liver damage. A

In recent years, the intersection of biotechnology and plant biology has led to transformative developments in drug production, highlighting a pivotal turning point in the sustainable manufacturing of vital medicines. Among these advancements is the use of tobacco plants to synthesize baccatin III,

A critical patient is confronted with unsettling news: her colon cancer has returned despite rigorous chemotherapy treatment. Facing the daunting challenge of deciding the next steps, she wonders why there aren't more effective treatment options available. This poignant scenario echoes the broader

In recent years, the field of robotics has witnessed a paradigm shift, moving from traditional control techniques to more innovative, vision-based learning systems. This transformation is driven by groundbreaking advancements in artificial intelligence and machine learning, fundamentally changing

Modern medicine continually strives to overcome the limitations of traditional treatments for rare genetic disorders, seeking transformative solutions that can significantly improve patients' lives. Among these conditions, hemophilia B—a genetic disorder inhibiting blood clotting primarily in

In a world where humans are still grappling with the limitations of healing after severe injury, the axolotl offers a tantalizing glimpse into the realm of science fiction becoming science fact. Known for their extraordinary capacity to regenerate whole limbs with precise anatomical detail,

The UK has taken a monumental step in the fight against extensive-stage small cell lung cancer (SCLC) with the recent approval of Hetronifly. This approval by the Medicines and Healthcare products Regulatory Agency (MHRA) introduces Hetronifly as the first anti-PD-1 monoclonal antibody available in

The world of regenerative medicine has been animated by a remarkable breakthrough in tissue engineering, involving the creation of liver organoids capable of developing their own vascular systems. Emerging from a collaborative effort between scientists at Cincinnati Children's Hospital Medical